Fundz

Circle Pharma Raises $45 Million in Series B Financing

PRIVATEMar 17, 2020

Amount Raised

$45 Million

Round Type

Series B

South San FranciscoHealthcareHealth Care

Description

Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $45 million in a Series B financing.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Circle Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Wavegate raised $2.4M on May 1, 2020.
  • Os Therapies raised an undisclosed amount on May 1, 2020.
  • PAVmed raised $4.1M on May 1, 2020.
  • FOLX HEALTH raised $4.3M (Seed) on May 1, 2020.
  • Novabay raised an undisclosed amount on May 1, 2020.
  • Suturegard Medical raised $375K (Seed) on April 30, 2020.

Who to call at Circle Pharma, and when

A new round usually means Circle Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Circle Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Circle Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Circle Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Circle Pharma

Location

681 GATEWAY BLVD

South San Francisco, California, United States

About

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Circle Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts19 people are listed at Circle Pharma. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Circle Pharma's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Circle Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.